NorthRock Partners LLC Sells 2,042 Shares of Zoetis Inc. (NYSE:ZTS)

NorthRock Partners LLC reduced its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 36.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,511 shares of the company’s stock after selling 2,042 shares during the quarter. NorthRock Partners LLC’s holdings in Zoetis were worth $686,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of ZTS. Sarasin & Partners LLP grew its holdings in Zoetis by 546.3% during the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock valued at $390,682,000 after purchasing an additional 1,904,899 shares during the period. Swedbank AB bought a new stake in Zoetis in the 1st quarter valued at about $210,815,000. International Assets Investment Management LLC lifted its holdings in Zoetis by 41,235.7% during the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock valued at $183,652,000 after purchasing an additional 937,700 shares during the last quarter. Marshall Wace LLP boosted its position in Zoetis by 7,608.6% during the second quarter. Marshall Wace LLP now owns 835,684 shares of the company’s stock worth $144,874,000 after purchasing an additional 824,843 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of Zoetis by 1.0% in the first quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock worth $6,895,235,000 after purchasing an additional 414,605 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

ZTS has been the subject of several analyst reports. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. BTIG Research raised their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Piper Sandler lifted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Stifel Nicolaus lifted their target price on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $221.44.

Zoetis Trading Up 0.1 %

Shares of ZTS opened at $175.27 on Wednesday. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The company has a market capitalization of $79.41 billion, a P/E ratio of 32.95, a P/E/G ratio of 2.68 and a beta of 0.90. The company has a debt-to-equity ratio of 1.32, a current ratio of 3.45 and a quick ratio of 2.09. The firm’s 50 day simple moving average is $188.71 and its 200 day simple moving average is $179.23.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 52.59%. The firm’s revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.36 EPS. Sell-side analysts forecast that Zoetis Inc. will post 5.91 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a dividend of $0.432 per share. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.99%. Zoetis’s dividend payout ratio (DPR) is presently 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.